investigators considered them unrelated, but no long-term oncology safety data exists)
The beta-3 adrenergic pathway that AOD 9604 activates is highly expressed in visceral adipose tissue, making it a targeted tool for belly fat reduction
The preclinical evidence is encouraging
Improved Glucose and Lipid Metabolism : Experimental studies demonstrate that suppression of NNMT activity with 5-Amino-1MQ correlates with improved glucose tolerance and reduced hepatic lipid accumulation
For example, athletes with high metabolic demands, vegans who consume no dietary B12, or individuals with chronic malabsorption issues like Crohns disease may find they feel their best with a bi-weekly (every two weeks) injection
Some possible peptide therapy side effects include: Hives, swelling, or breathing difficulty High blood pressure, rapid heart rate, and palpitations Nausea, vomiting, and diarrhea Headaches and dizziness Rashes Always consult a doctor before starting peptide therapy